Table 4.

Chloroquine plus primaquine treatment outcome of the study participants based on K–M analysis

Follow up days	At risk	Censored	Failure	Survived	K–M survival rate	K–M failure rate
Day 0	100	0	0	100	1.00	0.00
Day 1	100	0	0	100	1.00	0.00
Day 2	100	1	0	99	0.99	0.00
Day 3	99	1	1	97	0.98	0.01
Day 7	98	2	0	95	0.97	0.00
Day 14	96	1	3	91	0.94	0.03
Day 21	95	1	0	90	0.92	0.00
Day 28	94	1	0	89	0.94	0.00
Day 35	93	2	1	86	0.92	0.01
Day 42	91	0	2	84	0.92	0.02
Cure and failure rates of the drug on 28 days	Total cure rate % (95% CI)			96% (95% CI 89.7–98.5%)
	Total treatment failure % (95% CI)			4% (95% CI 1.5–10.3%)
Cure and failure rates of the drug on 42 days	Total cure rate % (95% CI)			92.6% (95% CI 85.1–96.4%)
	Total treatment failure % (95% CI)			7.4% (95% CI 3.6–14.9%)